Human Physiology · MU Plovdiv

25. Hemostasis and hemocoagulation. Vascular, thrombocyte and coagulation hemostasis. Fibrinolysis and anticoagulational mechanisms. Control of hemostasis.

Inside: 6 sections · 2 tables · 42 flashcards · 9 min

Essay 25 of 69 in the MU Plovdiv syllabus for Human Physiology (Dental Medicine, Year 2). The free AceMed note covers it in 6 sections, about 1,577 words (9 min of reading), with 42 flashcards.

In this note

  1. Vascular and platelet hemostasis
  2. Coagulation factors and the cascade
  3. Clot retraction and laboratory assessment
  4. Natural anticoagulants and the endothelium
  5. Fibrinolysis
  6. Laboratory and clinical aspects of fibrinolysis

Vascular and platelet hemostasis

This topic covers hemostasis: the vascular and platelet phases, the coagulation factors and cascade, and the laboratory tests. It also covers the natural anticoagulants, the fibrinolytic system and the control of hemostasis.

Hemostasis is the set of mechanisms that stops bleeding from an injured vessel while keeping blood fluid elsewhere. This topic covers the vascular reaction, the formation of the platelet plug (primary hemostasis), the plasma coagulation factors and the cascade that produces a stable fibrin clot (secondary hemostasis), clot retraction, and the basic laboratory tests. Fibrinolysis and the natural anticoagulants belong to the next topic.

Hemostasis runs as overlapping stages rather than strictly one after another:

  1. Vascular spasm: immediate local vasoconstriction.
  2. Platelet plug formation: adhesion, activation and aggregation of platelets.
  3. Blood coagulation: conversion of soluble fibrinogen to an insoluble fibrin network.
  4. Clot retraction, followed by fibrinolysis and tissue repair.

Vasoconstriction results from direct myogenic response of the injured smooth muscle, local axon reflexes, and vasoactive substances released by platelets and endothelium, especially thromboxane A₂, serotonin and endothelin. It is most effective in small vessels. Intact endothelium normally prevents clotting by producing prostacyclin (PGI₂) and nitric oxide, which inhibit platelets; injury exposes subendothelial collagen and tissue factor, which trigger hemostasis.

Platelets (thrombocytes) are anucleate fragments of bone marrow megakaryocytes, produced under the control of thrombopoietin (made mainly in the liver). Normal count is about 150–400 × 10⁹/L and lifespan about 7–10 days; old platelets are removed mainly by the spleen. They contain an open canalicular system, contractile proteins (actin, myosin, thrombosthenin) and two main granule types:

  • Dense granules: ADP, ATP, serotonin, Ca²⁺.
  • α-granules: fibrinogen, von Willebrand factor, factor V, PDGF, platelet factor 4.

Formation of the platelet plug proceeds in three steps:

  1. Adhesion: von Willebrand factor (vWF) bridges exposed collagen to the platelet receptor GPIb-IX-V; platelets also bind collagen directly via GPVI and integrin α2β1 (GPIa/IIa).
  2. Activation: shape change with pseudopodia, granule release, and synthesis of thromboxane A₂ from arachidonic acid via cyclooxygenase-1 (irreversibly blocked by aspirin). Negatively charged phospholipids (phosphatidylserine) are exposed on the surface and serve as the site for coagulation reactions.
  3. Aggregation: ADP, TXA₂ and thrombin activate the integrin GPIIb/IIIa (αIIbβ3), which binds fibrinogen and links neighbouring platelets. This positive feedback builds a loose, temporary plug.

Continue reading free

The whole note, all 6 sections, is free with an AceMed account, with its 42 flashcards. Standard adds flashcard recall, highlights and Ask AI.